These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24931902)

  • 1. Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells.
    Garrido P; Osorio FG; Morán J; Cabello E; Alonso A; Freije JM; González C
    J Cell Physiol; 2015 Jan; 230(1):191-8. PubMed ID: 24931902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
    Smolková K; Plecitá-Hlavatá L; Bellance N; Benard G; Rossignol R; Ježek P
    Int J Biochem Cell Biol; 2011 Jul; 43(7):950-68. PubMed ID: 20460169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
    Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
    J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells.
    O'Mahony F; Razandi M; Pedram A; Harvey BJ; Levin ER
    Mol Endocrinol; 2012 Dec; 26(12):2058-70. PubMed ID: 23028062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.
    Feron O
    Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
    Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
    Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
    Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
    Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
    Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells.
    Pola C; Formenti SC; Schneider RJ
    Cancer Res; 2013 Jul; 73(14):4571-8. PubMed ID: 23722547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
    Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
    PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous normal mammary epithelial mitochondria suppress glycolytic metabolism and glucose uptake of human breast cancer cells.
    Jiang XP; Elliott RL; Head JF
    Breast Cancer Res Treat; 2015 Oct; 153(3):519-29. PubMed ID: 26407856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic strategies targeting cancer--specific metabolism].
    Makinoshima H; Owada S; Esumi H
    Nihon Rinsho; 2015 Aug; 73(8):1296-301. PubMed ID: 26281681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt inhibitors reduce glucose uptake independently of their effects on Akt.
    Tan SX; Ng Y; James DE
    Biochem J; 2010 Nov; 432(1):191-7. PubMed ID: 20819080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
    Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
    Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor effect of GDC-0941 alone and in combination with rapamycin in breast cancer cells.
    Zheng J; Zou X; Yao J
    Chemotherapy; 2012; 58(4):273-81. PubMed ID: 23006739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.
    Eastlack SC; Dong S; Ivan C; Alahari SK
    Mol Cancer; 2018 Jul; 17(1):100. PubMed ID: 30012170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.